MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis (Q47809505)

5 February 2018

title

MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis (English)

1 reference

5 February 2018

author name string

Vázquez-García MN

1

1 reference

5 February 2018

Aláez C

2

1 reference

5 February 2018

Olivo A

3

1 reference

5 February 2018

Debaz H

4

1 reference

5 February 2018

Pérez-Luque E

5

1 reference

5 February 2018

Burguete A

6

1 reference

5 February 2018

Cano S

7

1 reference

5 February 2018

de la Rosa G

8

1 reference

5 February 2018

Bautista N

9

1 reference

5 February 2018

Hernández A

10

1 reference

5 February 2018

Bandera J

11

1 reference

5 February 2018

Torres LF

12

1 reference

5 February 2018

Kershenobich D

13

1 reference

5 February 2018

Alvarez F

14

1 reference

5 February 2018

Gorodezky C

15

1 reference

5 February 2018

publication date

1 June 1998

1 reference

5 February 2018

published in

Journal of Hepatology

1 reference

5 February 2018

volume

28

1 reference

5 February 2018

issue

6

1 reference

5 February 2018

page(s)

985-990

1 reference

5 February 2018

Frequency and significance of antibody to double-stranded DNA in chronic active hepatitis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980347-4

7 January 2021

Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980347-4

7 January 2021

LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980347-4

7 January 2021

Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980347-4

7 January 2021

Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980347-4

7 January 2021

Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980347-4

7 January 2021

Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980347-4

7 January 2021

Characterization of liver cytokeratin as a major target antigen of anti-SLA antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980347-4

7 January 2021

Frequency and significance of antibodies to histones in autoimmune hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980347-4

7 January 2021

High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980347-4

7 January 2021

Association of autoimmune active chronic hepatitis with HL-A1,8.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980347-4

7 January 2021

Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980347-4

7 January 2021

Significance of HLA DR4 in type 1 autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980347-4

7 January 2021

Association of autoimmune hepatitis with HLA-Bw54 and DR4 in Japanese patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980347-4

7 January 2021

HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980347-4

7 January 2021

Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980347-4

7 January 2021

Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980347-4

7 January 2021

Two-locus involvement in the association of human leukocyte antigen with the extrahepatic manifestations of autoimmune chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980347-4

7 January 2021

Meeting report: International Autoimmune Hepatitis Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980347-4

7 January 2021

Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodies (LKM1)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980347-4

7 January 2021

HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980347-4

7 January 2021

HLA and Disease 1982 - A Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980347-4

7 January 2021

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980347-4

7 January 2021

Genetic predispositions for the immunological features of chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980347-4

7 January 2021

Susceptibility to type I diabetes: HLA-DQ and DR revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980347-4

7 January 2021

Pocket 4 of the HLA-DR(alpha,beta 1*0401) molecule is a major determinant of T cells recognition of peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980347-4

7 January 2021

10.1016/S0168-8278(98)80347-4

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018